AI vs Aging. Who will win this war?
Read more
Category: life extension
Calling all the Longevity Superheroes, science needs you! We are proud to launch our brand new campaign and this time there is a twist.
We have launched our Lifespan Heroes campaign to raise funds for LEAF so we can continue delivering quality content, exclusive interviews, scientific commentaries, advocacy and more. We have done an amazing job over the last two years with our volunteers but now we need some help from our heroes — the longevity community.
Spring is the best time to celebrate life and remember all the good things we have achieved to improve and protect human life. One of the organizations which contributed the most to the development of healthcare systems around the globe is the World Health Organization founded by the United Nations. WHO’s Constitution came into force on 7 April 1948 – a date we now celebrate every year as World Health Day.
The main goals of the WHO are to provide leadership on matters critical to health, engage in partnerships where joint action is needed, shape the research agenda, support the dissemination of knowledge among all nations, set norms and standards in healthcare, articulate ethical and evidence-based policies. Let’s remember the definition of health by the WHO:
Read more
Haven’t we all heard it a billion times? ‘There are other priorities’ more urgent than defeating ageing. This article attempts to rebut that objection.
Somebody think of the children!!!
—Every social justice warrior ever
Sigh.
Before I say anything else, let me say this objection is one of my favourite trump cards (together with the social disparity card), not to mention a well-known logical fallacy going by the name of appeal to worse problems.
Read more
It’s tricky to bring transhumanism into sharp focus. As with, say, feminism, the meaning of the word varies hugely between individuals who identify with it, and the level of commitment may vary between an occasional affirmation or a crusading passion. Like feminism, transhumanism has many factions, often at war with one another, or with the broader culture; as with feminism, a lot of people identify as transhumanist without spending much time learning what those who coined the term were actually on about. Transhumanism broadly considers technology as an emancipatory route to individual and/or collective transcendence over the ‘limitations’ of the human condition.
Read more
This contains information that is not in other articles on the same topic of David Sinclair:
“The results certainly sound encouraging. Before he started taking a 500mg NMN pill every morning, 47-year-old Professor Sinclair had his blood tested and was told his body had a biological age of 58.
After consuming NMN for three months, he was tested again and his biological age was 32.”
Read more
Billionaire investor Jim Mellon has joined the push to solve age-related diseases and bring rejuvenation biotechnology to the world.
Billionaire biotechnology investor Jim Mellon has unveiled an investment in an ambitious new venture which seeks to tackle ageing and age-related diseases.
Insilico Medicine is a big data analytics company which says its mission is to ‘extend healthy longevity’.
This is a ‘moonshot’ target in health which has seen investment from a number of ambitious research groups in the last few years.
Read more
New one from Liz.
Full Video ► https://goo.gl/tHvTF5
BioViva ► http://bioviva-science.com
Liz Parrish is the Founder and CEO of BioViva Sciences USA Inc. BioViva is committed to extending healthy lifespans using gene therapy. Liz is known as “the woman who wants to genetically engineer you,” she is a humanitarian, entrepreneur and innovator and a leading voice for genetic cures. As a strong proponent of progress and education for the advancement of gene therapy, she serves as a motivational speaker to the public at large for the life sciences. She is actively involved in international educational media outreach and sits on the board of the International Longevity Alliance (ILA). She is the founder of BioTrove Investments LLC and the BioTrove Podcasts which is committed to offering a meaningful way for people to learn about and fund research in regenerative medicine. She is also the Secretary of the American Longevity Alliance (ALA) a 501©(3) nonprofit trade association that brings together individuals, companies, and organizations who work in advancing the emerging field of cellular & regenerative medicine with the aim to get governments to consider aging a disease.
Parrish received two kinds of injections, which were administered outside the United States: a myostatin inhibitor, which is expected to prevent age-associated muscle loss; and a telomerase gene therapy, which is expected to lengthen telomeres, segments of DNA at the ends of chromosomes whose shortening is associated with aging and degenerative disease.
——-
Facebook: https://www.facebook.com/agingreversed
Tumblr: http://agingreversed.tumblr.com
Twitter: https://twitter.com/Aging_Reversed
Read more
Interest in rejuvenation biotechnology is growing rapidly and attracting investors.
- Jim Mellon has made an investment in Insilico Medicine to enable the company to validate the many molecules discovered using deep learning and launch multi-modal biomarkers of human aging
Monday, April 10, 2017, Baltimore, MD — Insilico Medicine, Inc, a big data analytics company applying deep learning techniques to drug discovery, biomarker development, and aging research today announced that it has closed an investment from the billionaire biotechnology investor Jim Mellon. Proceeds will be used to perform pre-clinical validation of multiple lead molecules developed using Insilico Medicine’s drug discovery pipelines and to advance research in deep learned biomarkers of aging and disease.
“Unlike many wealthy business people who rely entirely on their advisors to support their investment in biotechnology, Jim Mellon has spent a substantial amount of time familiarizing himself with recent developments in biogerontology. He does not just come in with the funding, but brings in expert knowledge and a network of biotechnology and pharmaceutical executives, who work very quickly and focus on the commercialization potential. We are thrilled to have Mr. Mellon as one of our investors and business partners”, said Alex Zhavoronkov, PhD, founder, and CEO of Insilico Medicine, Inc.
Read more